fluarix: Clinical Trials

19 trials of fluarix, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

18 completed, 1 withdrawn. 19 Phase 3, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	19	Completed 18, Withdrawn 1
Phase 2	1	Withdrawn 1

Follow fluarix: new trials by email Literature Review of fluarix trials Research Report on fluarix

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age mRNA-1010, Fluarix®, Influsplit® Tetra - Seasonal Influenza	Phase 3	Completed	ModernaTX, Inc.	40805	2024-09-16	2026-09-16
Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea Quadrivalent Recombinant Influenza Vaccine (RIV4), Quadrivalent inactivated influenza vaccine (IIV4) - Influenza (Healthy Volunteers)	Phase 3	Completed	Sanofi Pasteur, a Sanofi Company	301	2021-12-07	2025-09-11
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya Quadrivalent Inactivated Influenza Vaccine (QIV), Inactivated Polio Vaccine, Double Dose QIV - Influenza, Human, HIV	Phase 2 / Phase 3	Withdrawn	Centers for Disease Control and Prevention		2014-04-01	2014-04-10
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older Fluarix/Influsplit Tetra® (2013-2014 season) - Influenza	Phase 3	Completed	GlaxoSmithKline	117	2013-07-11	2018-09-07
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older Fluarix/Influsplit SSW® (2013-2014 season) - Influenza	Phase 3	Completed	GlaxoSmithKline	120	2013-07-01	2018-09-07
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age Quadrivalent influenza GSK2282512A vaccine, Fluarix - Influenza	Phase 3	Completed	GlaxoSmithKline	606	2012-11-01	2021-11-01
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above Fluarix/Influsplit SSW 2012-2013 - Influenza	Phase 3	Completed	GlaxoSmithKline	119	2012-07-10	2018-09-07
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) Pandemrix (GSK investigational influenza GSK2340272A vaccine), Fluarix™, Placebo - Influenza	Phase 3	Completed	GlaxoSmithKline	145	2009-09-08	2018-08-17
Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older GSK Bio's influenza vaccine GSK2186877A, Fluarix - Influenza	Phase 3	Completed	GlaxoSmithKline	526	2008-10-06	2018-08-17
Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children Fluarix, Fluzone - Influenza	Phase 3	Completed	GlaxoSmithKline	3317	2008-10-01	2018-07-31
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults Fluarix™ - Influenza	Phase 3	Completed	GlaxoSmithKline	120	2008-07-07	2018-08-17
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults Fluarix, GSK Biologicals Influenza Vaccine GSK576389A - Influenza	Phase 3	Completed	GlaxoSmithKline	1252	2007-10-15	2018-06-08
Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults Meningococcal vaccine GSK134612, Mencevax™ACWY, Fluarix™ - Infections, Meningococcal	Phase 3	Completed	GlaxoSmithKline	1352	2007-04-09	2018-09-25
Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children Fluarix™, Fluzone - Influenza	Phase 3	Completed	GlaxoSmithKline	3327	2006-11-02	2018-06-08
Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults Fluarix®, Boostrix® - Acellular Pertussis, Diphtheria	Phase 3	Completed	GlaxoSmithKline	1726	2006-10-23	2019-06-10
Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults Influenza vaccine (A/H3N2, A/H1N1, and B strains), Fluarix - Influenza	Phase 3	Completed	GlaxoSmithKline	660	2006-09-01	2016-10-07
Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above Fluarix - Influenza	Phase 3	Completed	GlaxoSmithKline	120	2006-07-01	2016-09-28
Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above Adjuvanted pandemic influenza candidate vaccine, Fluarix, Placebo - Influenza	Phase 3	Completed	GlaxoSmithKline	5075	2006-05-01	2018-07-23
Fluarix Immunogenicity and Safety Trial Fluarix - Influenza	Phase 3	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	1050	2004-12-01	2010-08-27

Conditions studied

Sponsors

Countries

Top investigators

Results publications